Fetal-maternal interface impedance parallels local NADPH oxidase related superoxide production by Guedes-Martins, L. et al.
Redox Biology 5 (2015) 114–123Contents lists available at ScienceDirectRedox Biologyhttp://d
2213-23
Abbre
DHE, di
coefﬁcie
dinucleo
eclamps
artery.
n Corr
Mulher
Portuga
E-m
elisabet
saraivaj
jafonso@
almeidajournal homepage: www.elsevier.com/locate/redoxResearch PaperFetal–maternal interface impedance parallels local NADPH oxidase
related superoxide production
L. Guedes-Martins a,b,c,d,n, E. Silva a,b,c, A.R. Gaio e,f, J. Saraiva a,b,c,d, A.I. Soares a,b,c, J. Afonso g,
F. Macedo h, H. Almeida a,b,c,i
a Department of Experimental Biology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
b IBMC-Instituto de Biologia Molecular e Celular, 4150-180 Porto, Portugal
c Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-319 Porto, Portugal
d Centro Hospitalar do Porto EPE, Departamento da Mulher e da Medicina Reprodutiva, Centro Hospitalar do Porto EPE, Largo Prof. Abel Salazar, 4099-001
Porto, Portugal
e Department of Mathematics, Faculty of Sciences, University of Porto, Rua do Campo Alegre, 4169-007 Porto, Portugal
f CMUP-Centre of Mathematics of the University of Porto, Rua do Campo Alegre, 4169-007 Porto, Portugal
g Department of Pharmacology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
h Department of Cardiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
i Obstetrics-Gynecology, Hospital-CUF Porto, 4100 180 Porto, Portugala r t i c l e i n f o
Article history:
Received 28 March 2015
Received in revised form
14 April 2015
Accepted 17 April 2015
Available online 20 April 2015
Keywords:
Aortic isthmus
Uterine artery
Doppler
Pulsatility index
Oxidative stress
NADPH oxidasex.doi.org/10.1016/j.redox.2015.04.007
17/& 2015 The Authors. Published by Elsevier
viations: AoI, aortic isthmus; BMI, body mass i
hydroethidium; DPI, diphenyleneiodonium; IC
nt; IUGR, intra-uterine growth restriction; NA
tide phosphate; NOX, NADPH oxidase; PI, pu
ia; ROS, reactive oxygen species; SD, standard
esponding author at: Centro Hospitalar do
e da Medicina Reprodutiva, Largo Prof. Ab
l.
ail addresses: luis.guedes.martins@gmail.com
efersilva@gmail.com (E. Silva), argaio@fc.up.p
p@hotmail.com (J. Saraiva), anasoares.alv@gm
med.up.pt (J. Afonso), ﬁlipe.macedo@hsjoao.
h@med.up.pt (H. Almeida).a b s t r a c t
Blood ﬂow assessment employing Doppler techniques is a useful procedure in pregnancy evaluation, as it
may predict pregnancy disorders coursing with increased uterine vascular impedance, as pre-eclampsia.
While the local causes are unknown, emphasis has been put on reactive oxygen species (ROS) excessive
production. As NADPH oxidase (NOX) is a ROS generator, it is hypothesized that combining Doppler
assessment with NOX activity might provide useful knowledge on placental bed disorders underlying
mechanisms.
A prospective longitudinal study was performed in 19 normal course, singleton pregnancies. Fetal
aortic isthmus (AoI) and maternal uterine arteries (UtA) pulsatility index (PI) were recorded at two time
points: 20–22 and 40–41 weeks, just before elective Cesarean section. In addition, placenta and placental
bed biopsies were performed immediately after fetal extraction.
NOX activity was evaluated using a dihydroethidium-based ﬂuorescence method and associations to
PI values were studied with Spearman correlations. A clustering of pregnancies coursing with higher and
lower PI values was shown, which correlated strongly with placental bed NOX activity, but less con-
sistently with placental tissue.
The study provides evidence favoring that placental bed NOX activity parallels UtA PI enhancement
and suggests that an excess in oxidation underlies the development of pregnancy disorders coursing
with enhanced UtA impedance.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article u
ndex; CI, conﬁdence interval;
C, intra-class correlation
DPH, nicotinamide adenine
lsatility index; PE, pre-
deviation; UtA, uterine
Porto EPE, Departamento da
el Salazar, 4099-001 Porto,
(L. Guedes-Martins),
t (A.R. Gaio),
ail.com (A.I. Soares),
min-saude.pt (F. Macedo),Introduction
In recent years, the range of ultrasound applications for the
study of blood ﬂow has increased remarkably due to device
improvements, extensive and reliable data collection, and the non-
invasive nature of the procedure. In particular, Doppler effect
assessment of the impedance of fetal and placental circulation has
become a routine operation during pregnancy evaluation and a
necessary tool in screening for impaired utero-placental circula-
tion [1,2].
Over the course of a pregnancy, remarkable circulatory changes
occur in the pelvis: on the one side is a developing foetus withnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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circulation has to adapt continuously to cope with such demands.
These distinct features make the uteroplacental interface a crucial
site of circulation whose impedance can be assessed by
approaching the aortic isthmus (AoI) on the fetal side and the
uterine arteries (UtA) on the maternal side. In this respect,
although different impedance parameters may be employed,
emphasis has been placed on the pulsatility index (PI) because of
its ability to better describe the velocity waveform [3,4].
During prenatal life, the parallel position of both cardiac ven-
tricles assigns a special position to the AoI, as it reﬂects the bal-
ance of the functional accomplishments and the individual terri-
torial impedances of the two ventricles [4,5]. Thus, the direction of
blood ﬂow in the aortic isthmus will depend on the relative dif-
ference between the upper body and the subdiaphragmatic cir-
culation supplying the lower body and placenta [6]. Abnormal
ﬂow patterns in the AoI, identiﬁed by high impedance values, have
been shown to be associated with fetal circulatory redistribution
[6–10]; in addition, routine AoI Doppler assessment has been
shown to predict perinatal and long-term neurodevelopmental
outcomes in placental insufﬁciency [6,11,12]. Indeed, the value of
AoI blood ﬂow assessment has been emphasized as changes in AoI
antedate umbilical artery ﬁndings [7].
On the mother's side, a normal uterine artery waveform reﬂects
successful vascular remodelling at the uterine placental bed that
includes the decidua and part of the myometrium [13,14]. In early
pregnancy, the UtA Doppler waveform exhibits a rapid increase
and decrease in systolic ﬂow velocity that is followed by a notch in
the early diastole [15,16]. This feature, which usually recedes as
the pregnancy progresses [3,16] contributes to a mean diastolic
velocity rise and a UtA-PI value reduction [3,17]. Interestingly, in a
group of unselected pregnant women at 22–24 weeks, enhanced
uterine artery PI was reported to have a 69% sensitivity for pre-
eclampsia (PE) and the appearance of intra-uterine growth
restriction (IUGR) in the following weeks, a value that rose to 83%
in cases of protodiastolic notch persistence [18]. Although the
detection rate of PE as a result of enhanced UtA-PI was found to be
superior to the use of a patient’s epidemiological data [19], addi-
tional conditions must be met. Other reports have indicated that
abnormal UtA impedance at 22 weeks and PE establishment were
signiﬁcantly correlated only in the case of poor fetal outcome,
including IUGR and preterm birth [20,21]. More recently, top
decile PI values and bilateral notching were considered to have
good predictive value for enhanced risk of stillbirth resulting from
placental factors [22]. As a corollary favouring the relevance of UtA
Doppler impedance, an extensive meta-analysis [23] concluded
that an enhanced second trimester PI combined with a notch was
a good predictor of PE in low- and high-risk patients and of severe
IUGR in low-risk patients. Moreover, the ﬁndings supported the
recommendation to employ PI and notching uterine artery
assessment in daily clinical practice [23]. Most of the referred
obstetrical adverse conditions were recognized to result from
abnormal placental bed remodelling [14], but despite a wealth of
structural information, there is still insufﬁcient knowledge
regarding local regulation during placentation.
The involvement of the process of biological oxidation was
proposed. The local, continued production of reactive oxygen
species (ROS) is a cellular requirement that, in small and balanced
amounts, appears to exert a beneﬁcial role on normal pregnancies.
This context is relevant to the effect of ROS generated by NADPH
oxidase (NOX) activity in the uterus and placenta where, through
the activation of NF-κB, they regulate local angiogenesis [24,25]
and play a relevant role in normal placental bed establishment.
By contrast, excessive ROS production results in oxidatively
stressful conditions, inﬂammation, circulatory derangement, and
placental bed cell apoptosis or necrosis. These events may occurtransiently during labour in a fashion consistent with ischaemia-
reperfusion injury [26]; when lasting longer, or throughout the
pregnancy, they may result in placental function impairment
[27,28] and serious pregnancy complications [24,28].
Despite the likelihood of the process of ROS production, the
identity and contribution of the redox players involved have
remained unknown. To gain a better understanding, it is reason-
able to address putative contributors as part of a wider approach.
Therefore, we hypothesize that redox status, measured as the NOX
activity at the placental bed and in the placenta, relates to blood
ﬂow impedance measured at the fetal aortic isthmus and at the
maternal uterine arteries.Materials and methods
Subjects
This study was approved by the local ethics committee of
Centro Hospitalar do Porto–Unidade Maternidade Júlio Dinis and
all subjects provided written informed consent [IRB protocol
number: 133/10 (086-DEFI/126-CES)]. The methods were per-
formed in accordance with the approved guidelines.
The study was performed from January 2010 to December 2013.
Inclusion criteria were: healthy normotensive parturient with
singleton term pregnancies and gestational age Z40 weeks,
scheduled for elective cesarean section under spinal anesthesia
due to fetal breech presentation, suspected cephalopelvic dis-
proportion, or previous caesarean. Acceptable medications were
folic acid, vitamins, and iron supplements.
Exclusion criteria were: patients in labour or with ruptured
membranes; those with multiple gestations, coagulopathy, dia-
betes, or any pregnancy-induced hypertension including pre-
eclampsia; and those receiving β-tocolytic drugs.
Gestational age was calculated by the crown-rump length
between 11 and 14 weeks [29] by several experienced sono-
graphers from the Prenatal Diagnosis Department of our
institution.
On the day of caesarean section, biometrical data were col-
lected and the patients were observed by a senior specialist who
also reviewed their medical records.
The subarachnoid block was performed in the surgical suite
using a combined needle-through-needle spinal-epidural techni-
que (typical for caesarean section at our institution) with an epi-
dural 18-G Tuohy needle and 27-G subarachnoid pencil point
needle. Spinal anesthesia comprised 8–9 mg of hyperbaric bupi-
vacaine (5 mg/ml) and 2–2.5 mg sufentanil (5 mg/ml) administered
intrathecally, targeting the T4-S4 dermatomes.
The healthy condition of the infant was determined through
examination by a neonatologist at birth and 1 month after birth.
Doppler ﬂow assessment
Ultrasound examinations were performed using Voluson 730
Pro (GE Healthcare Technologies, Milwaukee, WI, USA) ultrasound
equipment containing multifrequency transabdominal transducers
(GE Healthcare Probe Type RAB4-8L) at any time of the day, during
the second trimester routine scan (ﬁrst time point), and immedi-
ately before the intrathecal blockade (second time point) for cae-
sarean section.
All measurements were performed by a single experienced
investigator (L.G-M; 6 years of experience in obstetric and
gynaecologic ultrasound) to minimize inter-observer variability.
Intra-observer reliability was estimated from two consecutive
readings of the pulsatility indexes in the UtA and AoI. Smokers
Table 1
Characteristics and obstetric data of the 19 women included in the study.
N (%)
Age, years (mean, SD) 31.2 (5.0)
Parity 0 14 (74%)
4 0 5 (26%)
Body Mass Index, kg/m2 (mean, SD)a 30.6 (5.9)
Smoking No 18 (95%)
Yes 1 (5%)
GA at delivery (weeks) (mean 7 SD) 40.5 (0.3)
Apgar Index 5′ o 7 0 (0)
Birth weight at delivery (g) (mean 7 SD)b 3354 (398) 
GA, gestational age; SD, standard deviation.
a BMI: measured at Caesarean section day.
b Birth weight in the sample corresponding to the 10th percentile was 2904 g.
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examination.
For uterine artery evaluation, the probe was placed on the
lower abdominal quadrants and angled medially, and color Dop-
pler imaging was used to localize the uterine artery as it crossed
over the external iliac artery. In all cases, an angle less than 30°
was assured before the pulsed Doppler probe was placed over the
entire vessel width. Angle correction was then applied, and the
signal was updated until three similar consecutive waveforms
were found to calculate the left and right uterine artery pulsatility
indexes using the device software. The mean UtA-PIs in the left
and right arteries were then determined.
For AoI evaluation, all recordings used for measurements were
sampled from the longitudinal aortic arch and performed in the
absence of fetal movements. The scanning plane was adjusted to
obtain an insonation angle o30°. The ﬁlter was set at 50 Hz and
the energy output levels used were lower than 50 mW/cm2.
Placenta and placental bed biopsies
Biopsies of the placenta and placental bed were performed by
open biopsy during caesarean section immediately after fetal
extraction and prior to oxytocin administration. Using tissue
scissors, two fragments approximately 105 mm2
(width  depth) were obtained. The ﬁrst fragment was collected
from the placental bed and the second was obtained from the
central area of the placental maternal surface. In individual cases,
because of a small uterine bleeding site, we proceeded to hae-
mostasis control using an isolated absorbable synthetic suture
(Polyglactin 910, 2/0). After collection under aseptic conditions,
the samples were brieﬂy washed in saline solution and immedi-
ately frozen in liquid nitrogen before being stored at  80 °C.
Dihydroethidium conversion
O2 production from NADPH oxidase was evaluated using a
dihydroethidium (DHE)-based ﬂuorescence method [30,31]. DHE
is used in ﬂuorimetric detection assays because upon reaction with
superoxide anions, it is converted to 2-hydroxyethidium, following
DNA intercalation, emits red ﬂuorescence.
Placenta and placental bed samples were homogenized in a
glass-to-glass homogenizer in cold HEPES buffer (25 mM) con-
taining EDTA (1 mM) and phenylmethyl-sulfonyl ﬂuoride (PMSF)
(0.1 mM). Protein content was assayed by the Bradford method
[32] and 12.5 mg of homogenate were used for the assay. Tissue
homogenates were incubated in HEPES/EDTA buffer with DHE
(20 mM), salmon testes DNA (0.5 mg/ml), and NADPH (1 mM).
Superoxide dismutase (200 U/ml) was used to conﬁrm the speci-
ﬁcity of the method. To determine whether NADPH oxidase was
the source of O2 an inhibitor of NOX (diphenylene iodonium,
DPI, 500 mM) was used. The effects of a xanthine oxidase inhibitor
(oxipurinol, 500 mM) and a nitric oxide synthase inhibitor (nitro-L-
arginine methylester, L-NAME, 500 mM) were also evaluated to
exclude other possible contributors for the O2 2-hydro-
xyethidium mediated ﬂuorescence [Supplementary Fig. S1]. It was
thus demonstrated that, under the experimental conditions used,
the observed increase in ﬂuorescence is mainly due to NOX
activity; as such, DHE conversion will be considered an indicator of
NOX activity. The reaction was followed for 15 min at 37 °C.
Fluorescence was measured in a ﬁnal volume reaction of 200 ml at
480 nm-excitation and 580 nm-emission using a ﬂuorescence
microplate reader (Spectramax Gemini, Molecular Devices, Sun-
nyvale, CA, USA). The results were expressed as ﬂuorescence
arbitrary units per 15 min per 12.5 mg of protein.
All drugs were purchased from Sigma Aldrich, St. Louis, MO,
USA.Statistical analysis
Intra-class correlation coefﬁcients (ICC) and 95% conﬁdence
intervals (CIs) were calculated with a two-way mixed-effects
model. The reliability coefﬁcient, which is the difference value that
will be exceeded by only 5% of pairs of measurements on the same
subject, was calculated as 1.96 times the standard deviation (SD) of
the difference between pairs of repeated measurements [33].
All remaining statistical analysis used only non-parametric
techniques. Sample correlations were evaluated by the Spearman
rank correlation coefﬁcient. The statistical signiﬁcance of the dif-
ference between the medians of a continuous variable in two
disjoint groups was assessed by the Mann–Whitney test. Cluster-
ing of longitudinal PI data were obtained from the application of
the K-means algorithm implemented with the Euclidean distance
[34].
The clustering algorithm was run several times considering 40
different starting conditions and varying the number of clusters
from 2 to 3. Varying the initial conditions increased the chances of
reaching a global maximum whereas varying the number of
clusters enabled the selection of the correct number of clusters.
The sample size was the main reason for the upper bound of the
number of clusters used in this paper. The ﬁnal clustering struc-
ture was chosen based upon the clinical interpretation of the
obtained groups and the statistical criteria of Calinsky & Harabatz
and Davies & Bouldin [35].
Clustering was performed on the group of PI individual time
proﬁles, and separately for each evaluated artery. The NOX activity
within each obtained class was then identiﬁed and comparisons
across clusters were also considered. This procedure was thought
to be more informative than simply studying the correlations
between each enzymatic activity and the PI values collected at
each of the evaluation periods.
All statistical analyses were performed using the R language
and software environment for statistical computation, version
2.12.1 [36]. The signiﬁcance level was set at 0.05.Results
A total of 19 pregnant women at term were considered eligible
for this study according to the established inclusion/exclusion
criteria, and their characteristics and pregnancy outcomes are
depicted in Table 1. Their ages ranged from 22 to 41 years old, and
this was the ﬁrst pregnancy for 74% of the women.
The median gestational age at the time of Doppler measure-
ments was 21.0 weeks (range: 20–22 weeks) at the ﬁrst time point
and 40.6 weeks (range: 40–41 weeks) at the second time point.
Fig. 1. Doppler ﬂow velocity waveforms obtained from the fetal aortic isthmus (panel A) and maternal uterine artery (panel B). panel A: The aortic Isthmus (AoI) is the
segment of the aorta located between the origin of the left subclavian artery and the connection of the ductus arteriosus to the descending aorta (*). Under physiological
conditions, the direction of ﬂow in the AoI is forward during the entire cardiac cycle. panel B: With the advent of color Doppler, the precise localization of the uterine arteries
became feasible; (þ) notch, abnormal waveform demonstrating increased impedance and early diastolic notch; (—) notch, normal pregnant waveform.
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obtained from the fetal aortic isthmus and maternal uterine
arteries. The reliability coefﬁcient for the UtA-PI measurements
was 0.102. The ICC for absolute agreement among the single
observer UtA-PI measurements was 0.990 with a 95% CI ranging
from 0.980 to 0.995. Similarly, the reliability coefﬁcient for theAoI-PI measurements was 0.302. The ICC for absolute agreement
among the single observer measurements was 0.976 with a 95% CI
ranging from 0.954 to 0.987.
Fig. 2 shows how the biopsies in the placenta and placental bed
were obtained.
Fig. 2. Placental and placental bed biopsies. (A) Placenta, central maternal surface
(1); (B) placental bed (2).
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was ﬁrst studied using Spearman correlation. From Table 2, AoI-PI
and the UtA-PI are positively associated with DHE-conversion
(both in the placental bed and in the placenta). In the placental
bed, the positive association between DHE-conversion and AoI-PI
at the ﬁrst evaluation period is only statistically signiﬁcant at the
0.09 level (p¼0.08), and no signiﬁcant association exists with AoI-
PI at the second evaluation period (p¼0.44). However, when
measured in placental tissue, DHE-conversion showed a sig-
niﬁcantly positive association with AoI-PI at second time point
(po0.01), but not at the ﬁrst time point (p¼0.164). There is a
signiﬁcant positive association between DHE-conversion at the
placental bed and UtA-PI at the ﬁrst and second time points, with
a stronger association at the ﬁrst time point. The enzymatic
activity of placental DHE-conversion was found to be signiﬁcantly
and positively associated with UtA-PI only at the ﬁrst time point
(p¼0.023). The positive UtA-PI association with placental bed
DHE-conversion at the ﬁrst time point was 44% higher than the
association observed with placental DHE-conversion.
Clustering the individual time proﬁles to analyze PI values at
the AoI and UtA independently allowed for the identiﬁcation of PI
trends. DHE-conversion was then compared across the obtained
partition of curves. This was used as a more comprehensive
methodology than simply considering correlations with PI values
at each of the evaluation time points.
For the AoI-PI measurements, two clusters were identiﬁed
(Fig. 4A): cluster A comprised 10 (52.6%) pregnant women and
cluster B comprised 9 (47.4%). No signiﬁcant relationship was
found between the clustering obtained and the DHE-conversion
measured in the placenta and the placental bed (Fig. 4B, Table 3).
When examining the UtA-PI values, two clusters were found(Fig. 4C): cluster A comprised 13 (68.4%) individuals and cluster B
comprised 6 individuals (31.6%). UtA cluster B contained all those
trajectories starting at higher UtA-PI values and is signiﬁcantly
associated with enhanced DHE-conversion in the placental bed
(Fig. 4D, Table 3). By contrast, the persistence of a notch in the
uterine artery at 20–22 weeks of gestation was signiﬁcantly
associated with high DHE-conversion in the placental bed, but not
in the placenta (Table 4).
Finally, we found that elevated DHE-conversion correlated
negatively with the Body Mass Index (BMI) of pregnant women
(Table 5). No signiﬁcant relationship was found between age and
the enzymatic activity studied.Discussion
During a pregnancy, both the foetus and the mother experience
substantial circulatory changes. Provided that vascular congenital
abnormalities are absent, the fetal circulation will follow an
intrinsic, species-related developmental programme; on the
mother's side, the pregnancy will impart to the placental bed a
variety of structural and functional changes that result in impor-
tant circulatory events.
At approximately 8 weeks of gestation, embryo-derived extra-
villous trophoblasts (EVTs) tend to surround decidual spiral
arteries, invade their walls, and assemble as cell plugs that ulti-
mately ﬁll their lumina from 10 weeks onwards [37]. Upon
replacing vessel endothelium and the smooth muscle cells, tro-
phoblasts subsequently extend to the innermost myometrium
layers and cluster around the spiral arteries. By 14 weeks, deep
myometrium involvement is evidenced by the trophoblast inva-
sion of the spiral arteries of the lumina. In time, this remodelling
process, deep placentation, will extend to most spiral arteries
[14,37].
An important consequence of the remodelled vessel is its
enlargement, implying the acquisition of capacitance properties,
reduced impedance to blood ﬂow, and reduced uterine artery PI.
However, if spiral artery remodelling is defective, the uterine
artery maintains resistance properties and its impedance increa-
ses. Such changes were found to associate with PE and other
obstetrical disorders with adverse implications for maternal and
fetal health [13,38,39].
In this context, it is useful to analyze blood ﬂow waveforms and
determine the UtA [3,20] and AoI [40] impedance. Although a high
AoI-PI is seen as an indicator of placental insufﬁciency and fetal
cardiac decompensation [41], there is substantial evidence that
high UtA impedance measured at 20–22 weeks is a good predictor
of serious pregnancy disorders and adverse fetal outcomes arising
in the following weeks until term [3,20,23,42].
As none of those adverse conditions affected the outcomes of
any of the pregnancies enrolled in the current study, both the ﬁrst
and second time-point measurements reﬂected a normal preg-
nancy course; as expected [3,17], UtA-PI decreased from the 20–22
week time point until term.
However, a closer analysis found two different clusters of UtA-
PI time trajectories, one (B) having a steeper PI reduction and the
other (A) showing a ﬂattened PI reduction. This ﬁnding indicates
that even in the absence of adverse clinical ﬁndings or outcomes,
coherent, speciﬁc UtA impedance trends exist, suggesting the
action of local regulatory mechanisms that are ﬁne-tuned at dif-
ferent levels. When vessel remodelling is deﬁcient or when pre-
disposing conditions exist, UtA-PI is likely to increase and to be
accompanied by clinical signs. The reason for this consequence of
abnormal remodelling is unknown, but the current study supports
the view that continued redox imbalance and established oxida-
tive stress is the underlying process.
Fig. 3. Plots of the sample values of DHE conversion against AoI-PI and UtA-PI measurements, at the ﬁrst (1) and second (2) time points, in the placenta and in the placental
bed (respectively, left and right columns).
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Table 2
Association between DHE-conversion activity and longitudinal AoI-PI and UtA-PI
values at the ﬁrst (1) and second (2) time points.
AoI-PI.1 AoI-PI.2 UtA-PI.1 UtA-PI.2
DHE-conversion(Δ Fluorescence A.U.)
Placenta
(n¼17)
0.353
(p¼0.164)
0.612
(p¼0.009)
0.548
(p¼0.023)
0.357
(p¼0.160)
Placental bed
(n¼19)
0.409
(p¼0.082)
0.187
(p¼0.444)
0.789
(po0.001)
0.501
(p¼0.029)
AoI, aortic isthmus; UtA, uterine artery; PI, pulsatility index; A.U., arbitrary units
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The high magnitude of the obtained ICC values from AoI and
UtA Doppler assessments allowed statistical analysis to ignore one
of the two measurements obtained from each woman. Because the
sonographer only performed one measurement in day-to-day
practice, the ﬁrst measurements were considered. Both left and
right main UtAs were investigated at the same time, as unilateral
measurement may provide erroneous results.
Clustering methods besides k-means could have been chosen
for the identiﬁcation of homogeneous classes of individual PIFig. 4. Panel AþC: individual time proﬁles of the AoI-PI and UtA-PI (left-hand side) an
cluster whereas all curves in green belong to the B cluster. Panel B þ D: boxplot of plac
and UtA-PI time trajectories.trajectories. More precisely, hierarchical methods, density-based
methods, grid-based methods, model-based methods, or other
partitioning methods could have been considered [43]. However,
the following points illustrate the advantages of the longitudinal
k-means algorithm: (1) it does not require any normality or
parametric assumptions within clusters; this is particularly
important in our study given its sample size and the fact that no
prior information was available; (2) it does not require any
assumptions regarding the shape of the individual trajectories;
and (3) it is independent from the time scaling used. In this study,
the clustering of the linear AoI-PI time proﬁles into 3 classes
provided a group consisting of only 2 individuals and that was
therefore discarded. Although the 3-cluster solution for UtA-PI
longitudinal proﬁles presented essentially balanced group pre-
valence (7, 6, and 6 members), it was not favored by the statistical
criteria. No signiﬁcant association was found between the proﬁle
partitions obtained for AoI and NOX activity. Although one of the
clusters presented a small dispersion of values and seemed to be
well-identiﬁed from that point of view, the other included a wide
range of enzymatic expression values. The 3-cluster solution
mentioned above was not capable of solving this lack of
correlation.d the two identiﬁed clusters, denoted by A and B; all curves in red belong to the A
ental bed and placental DHE-conversion in each of the clusters found for the AoI-PI
Table 3
Median (minimum–maximum) placental bed and placental DHE-conversion in each of the clusters (A and B) found for the AoI-PI and UtA-PI time trajectories.
All AoI.Cluster A AoI.Cluster B p UtA.Cluster A UtA.Cluster B p
DHE-conversion (Δ Fluorescence A.U.)
Placenta
(n¼17)
81.08 (46.12–104.52) 82.26 (62.50–104.52) 74.96 (46.12–95.22) 0.093 80.16 (46.12–103.09) 86.89 (62.50–104.52) 0.098
Placental bed
(n¼19)
19.72 (15.14–27.98) 21.59 (15.21–27.98) 19.13 (15.14–22.91) 0.400 18.72 (15.14–20.47) 25.39 (22.91–27.98) o0.001
p-Value from the Mann–Whitney test; AoI, aortic isthmus; UtA, uterine artery
Table 4
Median (minimum–maximum) placental bed and placental DHE-conversion in relation to the presence/absence of UtA notching (at the ﬁrst time point) and parity.
All UtA.Notch (–) UtA.Notch (þ) p Primiparous Parous p
DHE- conversion (Δ Fluorescence A.U.)
Placenta
(n¼17)
81.08 (46.12–104.52) 75.52 (46.12–103.09) 82.26 (62.50–104.52) 0.070 81.41 (46.12–103.09) 74.96 (54.71–104.52) 0.703
Placental bed
(n¼19)
19.72 (15.14–27.98) 18.29 (15.14–20.47) 24.64 (20.05–27.98) o 0.001 19.89 (15.14–27.98) 19.01 (15.63–24.64) 0.500
p-Value from the Mann–Whitney test, UtA, uterine artery.
Table 5
Spearman rank correlation coefﬁcient (p-value) between age/BMI and DHE-con-
version in the placental bed and in the placenta.
Age BMI1
DHE-conversion (Δ Fluorescence A.U.)
Placenta (n¼17) 0.081 (0.757) 0.277 (0.281)
Placental bed (n¼19) 0.158 (0.519) 0.465 (0.047)
a Measured at the second time point; BMI, Body Mass Index.
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The structural and functional integrity of the vascular system of
the placental bed is controlled by the endothelium [44]. Endo-
thelial cells produce a vast number of circulation regulators that
modulate signalling pathways whose activation requires balanced
ROS action [45]. In the uterus and placenta, substantial ROS pro-
duction is the result of NOX activity through its NOX1, NOX2,
NOX4, and NOX5 isoforms present in the endothelium, the myo-
metrium smooth muscle cells, the decidualized stromal cells, and
the syncytiotrophoblasts, where they generate H2O2 and super-
oxide anions [24,46,47].
The balanced production of ROS has local signalling properties
through the synthesis of nitric oxide, NO [48], a primary endo-
thelial cell vasodilator that is critical for endothelium transfor-
mation during pregnancy [49].
However, the balance may be disrupted when local conditions
enhance NOX activity and ROS production and lead to vessel dis-
orders. In human vascular samples, NOX-dependent superoxide
generation and abnormal endothelium-related responses were
found to correlate positively with the number of cardiovascular
risk factors present [50]. Aortic samples from NOX2 knockout mice
failed to respond to hypertensive experiments or to hypotensive
challenging as a result of a substantial reduction in superoxide
production [51]; interestingly, transgenic mice overexpressing
endothelial cell NOX2 exhibited basal activity similar to controls
but demonstrated remarkable sensitivity when challenged with
angiotensin II [52]. This is an important ﬁnding because the
involvement of this vasoactive peptide in pregnancy-induced
hypertensive disorders has long been recognized [53] and has
been interpreted as resulting from enhanced sensitivity [54].
As NOX production of superoxide anions intensiﬁes in smooth
muscle cells and human trophoblasts, persistent NF-kB activationensues [55], which reduces NO bioavailability. This set of condi-
tions promotes local inﬂammation and further oxidation, both
consistently implicated in the pathogenesis of the endothelial
dysfunction antedating PE and other disorders at the utero-pla-
cental interface [44,54,56,57].
In the current study involving pregnancies that followed a
normal course, a validated DHE-based ﬂuorescence method was
used as an indicator of NOX activity. Higher placental bed NOX
activity related DHE conversion at term was strongly correlated
with higher UtA-PI measured at 20–22 weeks (and at term) and
also correlated signiﬁcantly with notch persistence; as only AoI-PI
at term was signiﬁcant, the placental correlations are weaker,
emphasizing the value of UtA-PI as previously reported [39,42]. It
is uncertain whether fetal changes are independent of placental
bed redox modiﬁcations or are secondary to these modiﬁcations
because the foetoplacental unit is reliant on uterine artery perfu-
sion. The ﬁnding of a negative correlation between NOX activity at
the placental bed (but not at the placenta) and BMI is surprising in
view of the general recognition that obesity is associated with
oxidative stress [58]. However, this correlation may reﬂect only a
particular local regulation as adipocytes produce a variety of
peptides with modulatory abilities, including adiponectin, which
was found to down-regulate NOX activity [59,60].
We are convinced that the same mechanisms that enhance
placental bed NOX activity related DHE conversion in the identi-
ﬁed clusters are able to maintain higher UtA-PI in the same clus-
ters. Therefore, considering the strong correlation between the
higher levels of UtA-PI at 20–22 weeks and NOX activity in the
uterine tissue at term, it is conceivable that, should UtA-PI become
even higher, enhanced NOX activity would increase in a parallel
fashion. Eventually, excessive local oxidation would result in
abnormally high UtA-PI and unfavourable clinical outcomes; that
is, the intensity of the oxidative insult would mark the distinction
between functional disturbance and disease.
Although this study does not present placental bed NOX as a
disorder biomarker, it provides strong evidence that, at both the
uterus and the placenta, NOX is an important intervenient in the
redox balance at the human fetal–maternal interface. Further
knowledge of its regulation will provide useful insight for the
better management of hypertensive disorders of pregnancy.
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The longitudinal k-means algorithm also suffers from some
drawbacks [34]. (1) There are no formal hypothesis tests to check
the validity of the partition. (2) The number of clusters must be
known a priori. (3) The algorithm convergence to a global max-
imum is not assured, and therefore one cannot be sure that the
best partition has been found. Another obvious limitation of the
statistical analysis in this study was its sample size. A larger
sample size would allow for the application of (semi-)parametric
models (such as ﬁnite mixture models for clustering and t-tests for
the evaluation of enzymatic activities within the clusters), which
are known to be less conservative than non-parametric approa-
ches (4). The intervention of other ROS producers and ROS sca-
vengers was not studied, thus limiting the interpretation of the
role of other ROS producers and antioxidant molecules.Conclusions
This study provides evidence that in normal pregnancies, there
is an important involvement of NOX mediated superoxide pro-
duction, at the fetal/maternal interface. Notably, it was the pla-
cental bed that exhibited stronger positive correlation between
NOX activity and UtA-PI.Authors' contributions
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